drug_id,canonical_name,chembl_pref_name,max_mechanism_score,top_disease,final_score,n_trials,trial_statuses,trial_source,example_condition,why_stopped,targets,target_details
D4EA1C27B88,dipyridamole,DIPYRIDAMOLE,15.6413,retinitis pigmentosa,15.6943,,,,,,; ,"[{""target_chembl_id"": ""CHEMBL1997"", ""target_name"": ""Equilibrative nucleoside transporter 1"", ""mechanism_of_action"": ""Equilibrative nucleoside transporter 1 inhibitor"", ""uniprot"": ""Q99808"", ""pdb_ids"": [""6OB6"", ""6OB7"", ""8TZI""], ""pdb_count"": 3, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}, {""target_chembl_id"": ""CHEMBL2363066"", ""target_name"": ""3',5'-cyclic phosphodiesterase"", ""mechanism_of_action"": ""3',5'-cyclic phosphodiesterase inhibitor"", ""uniprot"": ""O76074"", ""pdb_ids"": [""1RKP"", ""1T9R"", ""1T9S"", ""1TBF"", ""1UDT""], ""pdb_count"": 708, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DEE1B9E575D,pregabalin,PREGABALIN,14.2301,"developmental and epileptic encephalopathy, 42",13.227,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,,"[{""target_chembl_id"": ""CHEMBL2363032"", ""target_name"": ""Voltage-gated calcium channel"", ""mechanism_of_action"": ""Voltage-gated calcium channel modulator"", ""uniprot"": ""O95180"", ""pdb_ids"": [""9AYG"", ""9AYH"", ""9AYJ"", ""9AYK"", ""9AYL""], ""pdb_count"": 127, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D2B99AAD8AE,dabigatran,DABIGATRAN,13.2142,congenital prothrombin deficiency,12.7606,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,,"[{""target_chembl_id"": ""CHEMBL204"", ""target_name"": ""Prothrombin"", ""mechanism_of_action"": ""Thrombin inhibitor"", ""uniprot"": ""P00734"", ""pdb_ids"": [""1AI8"", ""1A2C"", ""1A3B"", ""1A3E"", ""1A46""], ""pdb_count"": 400, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D89B62CA048,colchicine,COLCHICINE,13.1364,lissencephaly due to TUBA1A mutation,13.0444,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",,"[{""target_chembl_id"": ""CHEMBL2095182"", ""target_name"": ""Tubulin"", ""mechanism_of_action"": ""Tubulin inhibitor"", ""uniprot"": ""P68371"", ""pdb_ids"": [""7UN1"", ""7UNG"", ""8J07"", ""8SH7"", ""5IJ0""], ""pdb_count"": 85, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D806E86F552,rosiglitazone,ROSIGLITAZONE,11.3925,type 2 diabetes mellitus,13.4337,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,,"[{""target_chembl_id"": ""CHEMBL235"", ""target_name"": ""Peroxisome proliferator-activated receptor gamma"", ""mechanism_of_action"": ""Peroxisome proliferator-activated receptor gamma agonist"", ""uniprot"": ""P37231"", ""pdb_ids"": [""3ADX"", ""1FM6"", ""1FM9"", ""1I7I"", ""1K74""], ""pdb_count"": 316, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DF961DD1B69,serine proteinase-1 (serp-1),.ALPHA.1-PROTEINASE INHIBITOR HUMAN,10.685,"neutropenia, severe congenital, 1, autosomal dominant",13.2471,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,,"[{""target_chembl_id"": ""CHEMBL248"", ""target_name"": ""Neutrophil elastase"", ""mechanism_of_action"": ""Leukocyte elastase inhibitor"", ""uniprot"": ""P08246"", ""pdb_ids"": [""1B0F"", ""1H1B"", ""1HNE"", ""1PPF"", ""1PPG""], ""pdb_count"": 37, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DAEFACAD9A6,plerixafor,PLERIXAFOR,9.0733,WHIM syndrome,9.6591,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,,"[{""target_chembl_id"": ""CHEMBL2107"", ""target_name"": ""C-X-C chemokine receptor type 4"", ""mechanism_of_action"": ""C-X-C chemokine receptor type 4 partial agonist"", ""uniprot"": ""P61073"", ""pdb_ids"": [""2K03"", ""2K04"", ""2K05"", ""2N55"", ""3ODU""], ""pdb_count"": 24, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DEFD923B5F0,glimepiride,GLIMEPIRIDE,8.9929,type 2 diabetes mellitus,8.4865,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,,"[{""target_chembl_id"": ""CHEMBL2096972"", ""target_name"": ""Sulfonylurea receptor 1, Kir6.2"", ""mechanism_of_action"": ""Sulfonylurea receptor 1, Kir6.2 blocker"", ""uniprot"": ""Q14654"", ""pdb_ids"": [""6C3O"", ""6C3P"", ""7S5T"", ""7S5X"", ""7S5Y""], ""pdb_count"": 16, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DFDC3E7766D,fasudil hydrochloride,FASUDIL HYDROCHLORIDE,8.7748,open-angle glaucoma,10.5995,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,,"[{""target_chembl_id"": ""CHEMBL2111459"", ""target_name"": ""Rho-associated protein kinase"", ""mechanism_of_action"": ""Rho-associated protein kinase inhibitor"", ""uniprot"": ""O75116"", ""pdb_ids"": [""4L6Q"", ""4WOT"", ""5U7Q"", ""5U7R"", ""6ED6""], ""pdb_count"": 48, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D11EFE4B560,cellgram-cli,RESATORVID,8.1232,major depressive disorder,9.0157,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,,"[{""target_chembl_id"": ""CHEMBL5255"", ""target_name"": ""Toll-like receptor 4"", ""mechanism_of_action"": ""Toll-like receptor 4 inhibitor"", ""uniprot"": ""O00206"", ""pdb_ids"": [""2Z62"", ""2Z63"", ""2Z65"", ""2Z66"", ""3FXI""], ""pdb_count"": 14, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D0367529924,trilipix,FENOFIBRIC ACID,7.838,type 2 diabetes mellitus,9.2424,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,,"[{""target_chembl_id"": ""CHEMBL239"", ""target_name"": ""Peroxisome proliferator-activated receptor alpha"", ""mechanism_of_action"": ""Peroxisome proliferator-activated receptor alpha agonist"", ""uniprot"": ""Q07869"", ""pdb_ids"": [""1I7G"", ""1K7L"", ""1KKQ"", ""2NPA"", ""2P54""], ""pdb_count"": 64, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D37FD05EBD0,gemfibrozil,GEMFIBROZIL,7.838,type 2 diabetes mellitus,7.6069,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",,"[{""target_chembl_id"": ""CHEMBL239"", ""target_name"": ""Peroxisome proliferator-activated receptor alpha"", ""mechanism_of_action"": ""Peroxisome proliferator-activated receptor alpha agonist"", ""uniprot"": ""Q07869"", ""pdb_ids"": [""1I7G"", ""1K7L"", ""1KKQ"", ""2NPA"", ""2P54""], ""pdb_count"": 64, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D42E3ACEE1C,canakinumab (acz885),CANAKINUMAB,7.1223,Muckle-Wells syndrome,8.8301,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,,"[{""target_chembl_id"": ""CHEMBL1909490"", ""target_name"": ""Interleukin-1 beta"", ""mechanism_of_action"": ""Interleukin-1 beta inhibitor"", ""uniprot"": ""P01584"", ""pdb_ids"": [""1HIB"", ""1I1B"", ""1IOB"", ""1ITB"", ""1L2H""], ""pdb_count"": 64, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DF549FE6806,prednisone,PREDNISONE,6.4954,glucocorticoid resistance,5.9658,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,,"[{""target_chembl_id"": ""CHEMBL2034"", ""target_name"": ""Glucocorticoid receptor"", ""mechanism_of_action"": ""Glucocorticoid receptor agonist"", ""uniprot"": ""P04150"", ""pdb_ids"": [""1M2Z"", ""1NHZ"", ""1P93"", ""3BQD"", ""3CLD""], ""pdb_count"": 58, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D90EA1EEAF3,aspirin,ASPIRIN,6.0571,ulcerative colitis,5.5632,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,,"[{""target_chembl_id"": ""CHEMBL2094253"", ""target_name"": ""Cyclooxygenase"", ""mechanism_of_action"": ""Cyclooxygenase inhibitor"", ""uniprot"": ""P35354"", ""pdb_ids"": [""5F19"", ""5F1A"", ""5IKQ"", ""5IKR"", ""5IKT""], ""pdb_count"": 8, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DA2266BEA0E,fentanyl,FENTANYL HYDROCHLORIDE,5.8368,Diarrhea,7.2364,,,,,,,"[{""target_chembl_id"": ""CHEMBL233"", ""target_name"": ""Mu-type opioid receptor"", ""mechanism_of_action"": ""Mu opioid receptor agonist"", ""uniprot"": ""P35372"", ""pdb_ids"": [""8EF5"", ""8EF6"", ""8EFB"", ""8EFL"", ""8EFO""], ""pdb_count"": 13, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D4084C7BEA9,heparin,HEPARIN,5.6354,hereditary antithrombin deficiency,5.7206,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,,"[{""target_chembl_id"": ""CHEMBL1950"", ""target_name"": ""Antithrombin-III"", ""mechanism_of_action"": ""Antithrombin-III activator"", ""uniprot"": ""P01008"", ""pdb_ids"": [""1ANT"", ""1ATH"", ""1AZX"", ""1BR8"", ""1DZG""], ""pdb_count"": 27, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D708A1CD663,mycophenolate mofetil,MYCOPHENOLATE MOFETIL,5.0061,retinitis pigmentosa,4.6561,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,,"[{""target_chembl_id"": ""CHEMBL2111369"", ""target_name"": ""Inosine-5'-monophosphate dehydrogenase (IMPDH)"", ""mechanism_of_action"": ""Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor"", ""uniprot"": ""P20839"", ""pdb_ids"": [""1JCN"", ""7RER"", ""7RES"", ""7RFE"", ""7RFF""], ""pdb_count"": 41, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D6C3578F2CD,simvastatin,SIMVASTATIN,4.7902,coronary artery disease,4.4122,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,,"[{""target_chembl_id"": ""CHEMBL402"", ""target_name"": ""3-hydroxy-3-methylglutaryl-coenzyme A reductase"", ""mechanism_of_action"": ""HMG-CoA reductase inhibitor"", ""uniprot"": ""P04035"", ""pdb_ids"": [""1DQ8"", ""1DQ9"", ""1DQA"", ""1HW8"", ""1HW9""], ""pdb_count"": 24, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D8C4CF6E760,ranolazine,RANOLAZINE,4.6517,atrial fibrillation,4.7051,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,; ,"[{""target_chembl_id"": ""CHEMBL1980"", ""target_name"": ""Sodium channel protein type 5 subunit alpha"", ""mechanism_of_action"": ""Sodium channel protein type V alpha subunit blocker"", ""uniprot"": ""Q14524"", ""pdb_ids"": [""2KBI"", ""2L53"", ""4DCK"", ""4DJC"", ""4JQ0""], ""pdb_count"": 13, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}, {""target_chembl_id"": ""CHEMBL2072"", ""target_name"": ""Sodium channel protein type 4 subunit alpha"", ""mechanism_of_action"": ""Sodium channel protein type IV alpha subunit blocker"", ""uniprot"": ""P35499"", ""pdb_ids"": [""6AGF"", ""6MBA"", ""6MC9""], ""pdb_count"": 3, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DB553DB9B52,olmesartan medoxomil,OLMESARTAN MEDOXOMIL,4.603,renal tubular dysgenesis of genetic origin,4.5333,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,,"[{""target_chembl_id"": ""CHEMBL227"", ""target_name"": ""Type-1 angiotensin II receptor"", ""mechanism_of_action"": ""Type-1 angiotensin II receptor antagonist"", ""uniprot"": ""P30556"", ""pdb_ids"": [""4YAY"", ""4ZUD"", ""6DO1"", ""6OS0"", ""6OS1""], ""pdb_count"": 6, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DC1BB95516A,montelukast sodium,MONTELUKAST SODIUM,3.9886,asthma,3.5936,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,,"[{""target_chembl_id"": ""CHEMBL1798"", ""target_name"": ""Cysteinyl leukotriene receptor 1"", ""mechanism_of_action"": ""Cysteinyl leukotriene receptor 1 antagonist"", ""uniprot"": ""Q9Y271"", ""pdb_ids"": [""6RZ4"", ""6RZ5""], ""pdb_count"": 2, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D7CCF59E651,mln1202,PLOZALIZUMAB,3.9526,cystic disease of lung,4.5888,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,,"[{""target_chembl_id"": ""CHEMBL4015"", ""target_name"": ""C-C chemokine receptor type 2"", ""mechanism_of_action"": ""C-C chemokine receptor type 2 inhibitor"", ""uniprot"": ""P41597"", ""pdb_ids"": [""2MLO"", ""2MLQ"", ""5T1A"", ""7P8X"", ""7XA3""], ""pdb_count"": 5, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D8F03B5A0B8,cholecalciferol,CHOLECALCIFEROL,3.9303,Hypocalcemic vitamin D-resistant rickets,4.0314,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,,"[{""target_chembl_id"": ""CHEMBL1977"", ""target_name"": ""Vitamin D3 receptor"", ""mechanism_of_action"": ""Vitamin D receptor agonist"", ""uniprot"": ""P11473"", ""pdb_ids"": [""1DB1"", ""1IE8"", ""1IE9"", ""1KB2"", ""1KB4""], ""pdb_count"": 52, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DDA794638B5,spironolactone,SPIRONOLACTONE,3.8606,glucocorticoid resistance,3.6742,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,,"[{""target_chembl_id"": ""CHEMBL1994"", ""target_name"": ""Mineralocorticoid receptor"", ""mechanism_of_action"": ""Mineralocorticoid receptor antagonist"", ""uniprot"": ""P08235"", ""pdb_ids"": [""1Y9R"", ""1YA3"", ""2A3I"", ""2AA2"", ""2AA5""], ""pdb_count"": 29, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D782642130E,vonapanitase,VONAPANITASE,3.7251,supravalvular aortic stenosis,4.3925,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,,"[{""target_chembl_id"": ""CHEMBL3713712"", ""target_name"": ""Elastin"", ""mechanism_of_action"": ""Elastin proteolytic enzyme"", ""uniprot"": ""P15502"", ""pdb_ids"": [], ""pdb_count"": 0, ""has_alphafold"": true, ""structure_source"": ""AlphaFold_only""}]"
DA3A4925EDD,temsirolimus,TEMSIROLIMUS,3.3819,atopic eczema,3.5069,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,,"[{""target_chembl_id"": ""CHEMBL1902"", ""target_name"": ""Peptidyl-prolyl cis-trans isomerase FKBP1A"", ""mechanism_of_action"": ""FK506-binding protein 1A inhibitor"", ""uniprot"": ""P62942"", ""pdb_ids"": [""1A7X"", ""1B6C"", ""1BKF"", ""1BL4"", ""1D6O""], ""pdb_count"": 87, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DE30E457830,tacrolimus,TACROLIMUS,3.3819,atopic eczema,3.2292,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,,"[{""target_chembl_id"": ""CHEMBL1902"", ""target_name"": ""Peptidyl-prolyl cis-trans isomerase FKBP1A"", ""mechanism_of_action"": ""FK506-binding protein 1A inhibitor"", ""uniprot"": ""P62942"", ""pdb_ids"": [""1A7X"", ""1B6C"", ""1BKF"", ""1BL4"", ""1D6O""], ""pdb_count"": 87, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D87DBD3350E,sirolimus,SIROLIMUS,3.3819,atopic eczema,3.4656,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,,"[{""target_chembl_id"": ""CHEMBL1902"", ""target_name"": ""Peptidyl-prolyl cis-trans isomerase FKBP1A"", ""mechanism_of_action"": ""FK506-binding protein 1A inhibitor"", ""uniprot"": ""P62942"", ""pdb_ids"": [""1A7X"", ""1B6C"", ""1BKF"", ""1BL4"", ""1D6O""], ""pdb_count"": 87, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D8948B2B7AC,temsirolimus + dexamethasone sodium phosphate,DEXAMETHASONE SODIUM PHOSPHATE,3.2477,glucocorticoid resistance,4.0265,,,,,,,"[{""target_chembl_id"": ""CHEMBL2034"", ""target_name"": ""Glucocorticoid receptor"", ""mechanism_of_action"": ""Glucocorticoid receptor agonist"", ""uniprot"": ""P04150"", ""pdb_ids"": [""1M2Z"", ""1NHZ"", ""1P93"", ""3BQD"", ""3CLD""], ""pdb_count"": 58, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D06B7204DAC,remodulin (treprostinil sodium),TREPROSTINIL SODIUM,3.2286,pulmonary arterial hypertension,3.2286,,,,,,,"[{""target_chembl_id"": ""CHEMBL1995"", ""target_name"": ""Prostacyclin receptor"", ""mechanism_of_action"": ""Prostanoid IP receptor agonist"", ""uniprot"": ""P43119"", ""pdb_ids"": [""8X79"", ""8X7A""], ""pdb_count"": 2, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D11E72629CD,midazolam,MIDAZOLAM,3.0459,Lennox-Gastaut syndrome,3.0475,,,,,,,"[{""target_chembl_id"": ""CHEMBL2093872"", ""target_name"": ""GABA-A receptor; anion channel"", ""mechanism_of_action"": ""GABA-A receptor; anion channel positive allosteric modulator"", ""uniprot"": ""P14867"", ""pdb_ids"": [""9CXA"", ""9CXB"", ""6CDU"", ""6D1S"", ""6D6T""], ""pdb_count"": 190, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D845361F0EA,dipyridamole + aspirin,ASPIRIN,3.0286,ulcerative colitis,3.7548,,,,,,,"[{""target_chembl_id"": ""CHEMBL2094253"", ""target_name"": ""Cyclooxygenase"", ""mechanism_of_action"": ""Cyclooxygenase inhibitor"", ""uniprot"": ""P35354"", ""pdb_ids"": [""5F19"", ""5F1A"", ""5IKQ"", ""5IKR"", ""5IKT""], ""pdb_count"": 8, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DF9FD38C966,pactimibe sulfate,PACTIMIBE SULFATE,2.9698,familial hypercholesterolemia,3.6536,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,; ,"[{""target_chembl_id"": ""CHEMBL2782"", ""target_name"": ""Sterol O-acyltransferase 1"", ""mechanism_of_action"": ""Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor"", ""uniprot"": ""P35610"", ""pdb_ids"": [""6L47"", ""6L48"", ""6P2J"", ""6P2P"", ""6VUM""], ""pdb_count"": 5, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}, {""target_chembl_id"": ""CHEMBL4465"", ""target_name"": ""Sterol O-acyltransferase 2"", ""mechanism_of_action"": ""Acyl coenzyme A:cholesterol acyltransferase 2 inhibitor"", ""uniprot"": ""O75908"", ""pdb_ids"": [""7N6Q"", ""7N6R""], ""pdb_count"": 2, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DBE0C0D1774,nitroglycerin,NITROGLYCERIN,2.7863,hypertension,2.5394,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,,"[{""target_chembl_id"": ""CHEMBL2111348"", ""target_name"": ""Soluble guanylate cyclase"", ""mechanism_of_action"": ""Soluble guanylate cyclase activator"", ""uniprot"": ""Q02153"", ""pdb_ids"": [""2WZ1"", ""3UVJ"", ""4NI2"", ""5MNW"", ""6JT0""], ""pdb_count"": 26, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DD26B9A973C,repatha,EVOLOCUMAB,2.778,familial hypercholesterolemia,3.4177,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,,"[{""target_chembl_id"": ""CHEMBL2929"", ""target_name"": ""Proprotein convertase subtilisin/kexin type 9"", ""mechanism_of_action"": ""Subtilisin/kexin type 9 inhibitor"", ""uniprot"": ""Q8NBP7"", ""pdb_ids"": [""2P4E"", ""2PMW"", ""2QTW"", ""2W2M"", ""2W2N""], ""pdb_count"": 43, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D8E7425BC16,evolocumab,EVOLOCUMAB,2.778,familial hypercholesterolemia,2.5909,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,,"[{""target_chembl_id"": ""CHEMBL2929"", ""target_name"": ""Proprotein convertase subtilisin/kexin type 9"", ""mechanism_of_action"": ""Subtilisin/kexin type 9 inhibitor"", ""uniprot"": ""Q8NBP7"", ""pdb_ids"": [""2P4E"", ""2PMW"", ""2QTW"", ""2W2M"", ""2W2N""], ""pdb_count"": 43, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DCD3082AD90,alirocumab,ALIROCUMAB,2.778,familial hypercholesterolemia,2.7706,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,,"[{""target_chembl_id"": ""CHEMBL2929"", ""target_name"": ""Proprotein convertase subtilisin/kexin type 9"", ""mechanism_of_action"": ""Subtilisin/kexin type 9 inhibitor"", ""uniprot"": ""Q8NBP7"", ""pdb_ids"": [""2P4E"", ""2PMW"", ""2QTW"", ""2W2M"", ""2W2N""], ""pdb_count"": 43, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D5094065EBE,atenolol,ATENOLOL,2.7649,hypertension,2.4721,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,,"[{""target_chembl_id"": ""CHEMBL213"", ""target_name"": ""Beta-1 adrenergic receptor"", ""mechanism_of_action"": ""Beta-1 adrenergic receptor antagonist"", ""uniprot"": ""P08588"", ""pdb_ids"": [""2LSQ"", ""7BTS"", ""7BU6"", ""7BU7"", ""7BVQ""], ""pdb_count"": 5, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DF04AEE46A4,nexlizet,BEMPEDOIC ACID,2.4095,familial hypercholesterolemia,2.9643,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",,"[{""target_chembl_id"": ""CHEMBL3720"", ""target_name"": ""ATP-citrate synthase"", ""mechanism_of_action"": ""ATP-citrate synthase inhibitor"", ""uniprot"": ""P53396"", ""pdb_ids"": [""3MWD"", ""3MWE"", ""3PFF"", ""5TDE"", ""5TDF""], ""pdb_count"": 35, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D3897AE464F,jardiance,EMPAGLIFLOZIN,2.3141,familial renal glucosuria,2.8225,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",,"[{""target_chembl_id"": ""CHEMBL3884"", ""target_name"": ""Sodium/glucose cotransporter 2"", ""mechanism_of_action"": ""Sodium/glucose cotransporter 2 inhibitor"", ""uniprot"": ""P31639"", ""pdb_ids"": [""7VSI"", ""7YNJ"", ""7YNK"", ""8HB0"", ""8HDH""], ""pdb_count"": 8, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D96174BF1BA,niacin/laropiprant,LAROPIPRANT,2.2613,pulmonary arterial hypertension,2.2613,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,,"[{""target_chembl_id"": ""CHEMBL4427"", ""target_name"": ""Prostaglandin D2 receptor"", ""mechanism_of_action"": ""Prostanoid DP receptor antagonist"", ""uniprot"": ""Q13258"", ""pdb_ids"": [], ""pdb_count"": 0, ""has_alphafold"": true, ""structure_source"": ""AlphaFold_only""}]"
D6208D4149F,urokinase,UROKINASE,2.1493,Quebec platelet disorder,2.5963,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,,"[{""target_chembl_id"": ""CHEMBL3286"", ""target_name"": ""Urokinase-type plasminogen activator"", ""mechanism_of_action"": ""Urokinase-type plasminogen activator exogenous protein"", ""uniprot"": ""P00749"", ""pdb_ids"": [""1C5W"", ""1C5X"", ""1C5Y"", ""1C5Z"", ""1EJN""], ""pdb_count"": 155, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DE162453E18,atorvastatin + aspirin + losartan + amlodipine,AMLODIPINE BESYLATE,2.1384,"developmental and epileptic encephalopathy, 42",2.6512,,,,,,,"[{""target_chembl_id"": ""CHEMBL2095229"", ""target_name"": ""Voltage-gated L-type calcium channel"", ""mechanism_of_action"": ""Voltage-gated L-type calcium channel blocker"", ""uniprot"": ""Q13936"", ""pdb_ids"": [""1T0J"", ""2BE6"", ""2F3Y"", ""2F3Z"", ""2LQC""], ""pdb_count"": 40, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
DE33B01E32B,rimonabant,RIMONABANT,2.0029,obesity,2.3926,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,,"[{""target_chembl_id"": ""CHEMBL218"", ""target_name"": ""Cannabinoid receptor 1"", ""mechanism_of_action"": ""Cannabinoid CB1 receptor antagonist"", ""uniprot"": ""P21554"", ""pdb_ids"": [""1LVQ"", ""1LVR"", ""2B0Y"", ""2KOE"", ""2MZ2""], ""pdb_count"": 30, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D2AECF38813,veliflapon (dg-031),VELIFLAPON,1.9094,bipolar disorder,1.9094,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,,"[{""target_chembl_id"": ""CHEMBL4550"", ""target_name"": ""Arachidonate 5-lipoxygenase-activating protein"", ""mechanism_of_action"": ""5-lipoxygenase activating protein inhibitor"", ""uniprot"": ""P20292"", ""pdb_ids"": [""2Q7M"", ""2Q7R"", ""6VGC"", ""6VGI""], ""pdb_count"": 4, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D4B113FFFDB,bupivacaine liposome,BUPIVACAINE,1.7995,atrial fibrillation,2.231,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,,"[{""target_chembl_id"": ""CHEMBL2072"", ""target_name"": ""Sodium channel protein type 4 subunit alpha"", ""mechanism_of_action"": ""Sodium channel protein type IV alpha subunit blocker"", ""uniprot"": ""P35499"", ""pdb_ids"": [""6AGF"", ""6MBA"", ""6MC9""], ""pdb_count"": 3, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D3036D78EAB,bms-823778,BMS-823778,1.7938,Hyperandrogenism due to cortisone reductase deficiency,2.2239,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,,"[{""target_chembl_id"": ""CHEMBL4235"", ""target_name"": ""11-beta-hydroxysteroid dehydrogenase 1"", ""mechanism_of_action"": ""11-beta-hydroxysteroid dehydrogenase 1 inhibitor"", ""uniprot"": ""P28845"", ""pdb_ids"": [""1XU7"", ""1XU9"", ""2BEL"", ""2ILT"", ""2IRW""], ""pdb_count"": 40, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D7B75B0197B,ticagrelor,TICAGRELOR,1.7195,platelet-type bleeding disorder 8,1.6461,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,,"[{""target_chembl_id"": ""CHEMBL2001"", ""target_name"": ""P2Y purinoceptor 12"", ""mechanism_of_action"": ""Purinergic receptor P2Y12 negative allosteric modulator"", ""uniprot"": ""Q9H244"", ""pdb_ids"": [""4NTJ"", ""4PXZ"", ""4PY0"", ""7PP1"", ""7XXI""], ""pdb_count"": 5, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D133E08FEBD,cangrelor,CANGRELOR,1.7195,platelet-type bleeding disorder 8,1.8893,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,,"[{""target_chembl_id"": ""CHEMBL2001"", ""target_name"": ""P2Y purinoceptor 12"", ""mechanism_of_action"": ""Purinergic receptor P2Y12 inhibitor"", ""uniprot"": ""Q9H244"", ""pdb_ids"": [""4NTJ"", ""4PXZ"", ""4PY0"", ""7PP1"", ""7XXI""], ""pdb_count"": 5, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D99B6E6CF0C,cilostazol,CILOSTAZOL,1.5564,retinitis pigmentosa,1.6034,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,,"[{""target_chembl_id"": ""CHEMBL241"", ""target_name"": ""cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A"", ""mechanism_of_action"": ""Phosphodiesterase 3A inhibitor"", ""uniprot"": ""Q14432"", ""pdb_ids"": [""7EG0"", ""7EG1"", ""7EG4"", ""7KWE"", ""7L27""], ""pdb_count"": 9, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D7460F02840,angiotensin 1-7,TALFIRASTIDE,1.2999,congenital prothrombin deficiency,1.6116,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,,"[{""target_chembl_id"": ""CHEMBL3559701"", ""target_name"": ""Proto-oncogene Mas"", ""mechanism_of_action"": ""Proto-oncogene Mas agonist"", ""uniprot"": ""P04201"", ""pdb_ids"": [], ""pdb_count"": 0, ""has_alphafold"": true, ""structure_source"": ""AlphaFold_only""}]"
D0E3D29E666,phenprocoumon,PHENPROCOUMON,1.1372,Hereditary combined deficiency of vitamin K-dependent clotting factors,1.3959,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,,"[{""target_chembl_id"": ""CHEMBL1930"", ""target_name"": ""Vitamin K epoxide reductase complex subunit 1"", ""mechanism_of_action"": ""Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor"", ""uniprot"": ""Q9BQB6"", ""pdb_ids"": [""6WV3"", ""6WV4"", ""6WV5"", ""6WV6"", ""6WV7""], ""pdb_count"": 6, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D503A274BC9,ezetimibe,EZETIMIBE,0.9812,familial hypercholesterolemia,0.9219,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,,"[{""target_chembl_id"": ""CHEMBL2027"", ""target_name"": ""NPC1-like intracellular cholesterol transporter 1"", ""mechanism_of_action"": ""Niemann-Pick C1-like protein 1 inhibitor"", ""uniprot"": ""Q9UHC9"", ""pdb_ids"": [""3QNT"", ""7DF8"", ""7DFW"", ""7DFZ"", ""7N4U""], ""pdb_count"": 7, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
D27509ED5E5,aspirin + ticagrelor,TICAGRELOR,0.8597,platelet-type bleeding disorder 8,1.0486,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,,"[{""target_chembl_id"": ""CHEMBL2001"", ""target_name"": ""P2Y purinoceptor 12"", ""mechanism_of_action"": ""Purinergic receptor P2Y12 negative allosteric modulator"", ""uniprot"": ""Q9H244"", ""pdb_ids"": [""4NTJ"", ""4PXZ"", ""4PY0"", ""7PP1"", ""7XXI""], ""pdb_count"": 5, ""has_alphafold"": true, ""structure_source"": ""PDB+AlphaFold""}]"
